Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.0634?guestAccessKey=372e77fe-6cf9-43e7-bc8f-1ca8260211e7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050423
JAMAONCO_OF:05042023
Assessment of Gender-Specific COVID-19 Case Fatality Risk per Malignant Neoplasm Type
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.0768?guestAccessKey=d9441c63-e315-4125-9722-f19c97741303&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042723
JAMAONCO_OF:04272023
JAMAONCO_OF:04202024
JAMAONCO_OF:04182023
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.0351?guestAccessKey=65c9d206-c7a1-4894-9411-8a774f9d8174&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041323
JAMAONCO_OF:04132023
Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 6, 2023 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.0339?guestAccessKey=dd45ac85-1221-4663-a7f3-ed10470de454&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040623 About The Study: This population-based study found that pregnancy-associated…
JAMAONCO_OF:04062023
Delayed or Forgone Care Due to Patient-Clinician Identity Discordance Among Cancer Survivors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2023.0242?guestAccessKey=a39b38ba-4e4d-4d8a-a4dd-4ba2d20e9a00&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033023
JAMAONCO_OF:03302023
JAMAONCO_OF:03232023
JAMAONCO_OF:03162023
JAMAONCO_OF:03092023
State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7835?guestAccessKey=388eea03-45b0-4567-a8ea-fefeae212733&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030223
HPV Vaccination Prevalence, Disproportionate Cancer Burden Among Veterans
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7944?guestAccessKey=551227e6-780c-4b79-84ed-0bfe9d6530b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030223
JAMAONCO_OF:03022023
Exposure to Cancer Drugs Without Confirmed Benefit After FDA Accelerated Approval
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7770?guestAccessKey=80c4bdee-ef27-42f2-88aa-eb1b1b2a8ecf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022323
Estimates, Projections of Global Economic Cost of 29 Cancers From 2020 to 2050
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 23, 2023 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7826?guestAccessKey=7b23f16f-8481-4de3-a0ff-10a755cb2857&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022323 About The Study: In this decision analytical modeling study,…
JAMAONCO_OF:02232023
Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7705?guestAccessKey=a36e7a63-84b7-4e03-b47b-a9af062d1c15&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021623
JAMAONCO_OF:02162023
Cancer in Transgender and Gender-Diverse Persons
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7173?guestAccessKey=221fc2da-7faa-46bf-a947-994e8989cfc0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020923
JAMAONCO_OF:02092023
Breast Cancer Diagnosis, Treatment, and Outcomes of Patients From Sex and Gender Minority Groups
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.7146?guestAccessKey=5044452f-d914-4408-a491-41b304732f6a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020223
JAMAONCO_OF:02022023
JAMAONCO_01262023
Long-term Trajectories of Physical Function Decline in Women With, Without Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 19, 2023 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6881?guestAccessKey=1f40577c-0a98-4662-8c17-d659b19a3069&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011923 About The Study: Survivors of cancer experienced accelerated declines…
JAMAONCO_OF:01192023
JAMAONCO_ADHOC:01132023
MRI-Guided vs CT-Guided Stereotactic Body Radiotherapy for Patients With Prostate Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6558?guestAccessKey=84398d76-f0eb-4521-aedf-eb8e63133b28&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011223
Effect of Machine Learning–Triggered Nudges on Serious Illness Conversations, End-of-Life Outcomes Among Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6303?guestAccessKey=992d1f64-f12e-43c6-bbdb-f2cb3ca98faf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011223
Incidence, Factors Associated With Suicide Among Patients Undergoing Surgery for Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 12, 2023 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6549?guestAccessKey=25d9622a-1ab9-4d82-9db2-5fbaa6a6996b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011223 About The Study: The incidence of suicide…
JAMAONCO_OF:01122023
Postoperative Restrictive Opioid Protocols, Changes in Opioid Prescribing, Chronic Use
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 5, 2023 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6278?guestAccessKey=a621554c-d2a3-4f1a-88cf-1e17713d89f6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010523 About The Study: Implementation of a restrictive opioid prescription…
JAMAONCO_OF:01052023
Association of COVID-19 Vaccination With Breakthrough Infections, Complications in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 29, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6815?guestAccessKey=24522c3a-b9d4-4e26-bf45-d58917926399&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122922 About The Study: In this large population-based study, patients…
JAMAONCO_OF:12292022
SARS-CoV-2 Spike Protein Antibody Response, Infection Severity in Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5974?guestAccessKey=8104ff79-e2ca-4536-8313-f6cf2bc9d3c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122222
JAMAONCO_OF:12222022
JAMAONCO_OF:12152022
JAMAONCO_OF:12082022
Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Receiving Cancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 1, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5623?guestAccessKey=492f0176-1a29-4c42-8737-9cad14a67fd4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120122 About The Study: The findings of this study suggest…
JAMAONCO_OF:12012022
Disparities in Inclusion of Racial, Ethnic Minority Groups in Prostate Cancer Clinical Trials
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 23, 2022 Media advisory: The full is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5511?guestAccessKey=f799505c-99e1-4b63-a9b1-95df0244791e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112322 About The Study: The results of this meta-analysis of 286…
JAMAONCO_OF:11232022
Rates of Routine Cancer Screening, Diagnosis Before vs After Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 17, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5481?guestAccessKey=a155d93d-a9e8-4b05-b0be-66f75cffca20&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111722 About The Study: In this cross-sectional study of data…
Association of Residential Racial, Economic Segregation With Cancer Mortality
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5382?guestAccessKey=64d5e78b-c977-480e-bec8-a7a695fb5338&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111722 About The Study: The findings of this…
JAMAONC_OF:11172022
JAMAONCO_11112022
JAMAONCO_OF:11102022
JAMAONCO_OF:11032022
Interplay of Immunosuppression, Immunotherapy Among Patients With Cancer and COVID-19
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5357?guestAccessKey=6675d993-046d-41dd-a65b-ff8ef1ddc33e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322
Fracture Risk Among Older Cancer Survivors Compared With Older Adults Without a History of Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5153?guestAccessKey=4b9ee6a0-8c06-4724-a94a-62b411d1afd9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322
Serious Adverse Event Reporting in Cancer Clinical Trials During the Pandemic
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4919?guestAccessKey=440e57f5-0e8a-4e92-b1fe-77c4de070477&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102722
JAMAONCO_OF:10272022
Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at Veterans Health Administration Facilities
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4319?guestAccessKey=64418a55-4d5c-4a34-aae3-4b74ebe425c2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102422
JAMAONCO_ADHOC:10232022
JAMAONCO_ADHOC:10242022
JAMAONCO_OF:10202022
JAMAONCO_OF:10132022
Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4649?guestAccessKey=246957dc-cae4-4aa6-939d-7509f42444e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101322 About The Study: Invasive breast cancer rates…
JAMAONCO_OF:10062022
JAMAONCO_OF:09292022
Identification of Deaths Caused by Cancer, COVID-19 in US From March to December 2020
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 29, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4315?guestAccessKey=109b8e0c-720b-4003-ae1b-b603a1faa0a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092922 About The Study: This analysis shows that in the…
JAMAONCO_OF:09222022
Inhibition of Omicron BA.1, BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4226?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092222
JAMAONCO_OF:09152022
JAMAONCO_ADHOC:09122022
JAMAONCO_OF:09082022
JAMAONCO_OF:09012022
Visual Abstract: Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3829?guestAccessKey=efae0fdc-ee29-440a-bcb1-3851ebb46e11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122 Visual Abstract Authors: Thierry…
Visual Abstract: Efficacy, Safety of Telaglenastat Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3511?guestAccessKey=c6ad7a6b-caf2-411c-a706-d6e65b18d0c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122 Visual Abstract…
JAMAONCO_OF:08252022
Reporting of Race and Hispanic Ethnicity in Breast Cancer Studies From the National Cancer Database
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3527?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3677?guestAccessKey=14d8ef3b-d59d-4322-aee4-d8ef1be7480d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522
JAMAONCO_08182022
Visual Abstract: Etoposide, Cisplatin vs Irinotecan, Cisplatin for Neuroendocrine Carcinoma of Digestive System
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3395?guestAccessKey=686b68ae-7de7-4777-9e3c-13a3fe86deb8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822 Visual Abstract Authors: Chigusa…
JAMAONC_OF:08112022
Antibody Response of 3-Dose COVID-19 Vaccination Schedule in Immunocompromised Patients With Hematologic Cancers
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 11, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3227?guestAccessKey=0b9a95d7-73d1-49c0-a5a8-c690dae47ecc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081122 About The Study: In this study that included 584…
JAMAONCO_OF:08042022
Association Between PSA Screening, Prostate Cancer Mortality Among Non-Hispanic Black, Non-Hispanic White Veterans
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 4, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2970?guestAccessKey=06430554-cf5a-42e4-b950-adbebba956fa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080422 About The Study: In this study of 45,800 U.S….
JAMAONCO_OF:07282022
Daily Insulin Dose, Cancer Risk Among Patients With Type 1 Diabetes
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 28, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2960?guestAccessKey=b87b1296-2d13-4778-adc8-6ef8cfe9425f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822 About The Study: This study investigated the associations of…
Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2952?guestAccessKey=3997d5dd-38bd-4549-a346-9f6ad30ddf3c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822
JAMAONCO_OF:07212022
Incidence of Anaplastic Large-Cell Lymphoma of the Breast in US
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2624?guestAccessKey=4c6c9ff4-348c-4a3d-be6d-a933bd35a8b4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072122
JAMAONCO_OF:07142022
Visual Abstract: Preoperative mFOLFIRINOX With vs Without Hypofractionated Radiotheraphy for Borderline Resectable Adenocarcinoma of the Pancreas
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 14, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2319?guestAccessKey=19be8691-33c6-45fa-a57d-449b14057ad6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071422 Visual Abstract…
JAMAONCO_OF:07072022
Plant-Based, Ketogenic Diets As Diverging Paths to Address Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1769?guestAccessKey=6fcb6393-e7d5-4721-8be2-c93131f59772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722
Worldwide Association of COVID-19 Pandemic Measures With Cancer Screening
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2617?guestAccessKey=bad2cff1-e56b-4697-840b-d5046c557c22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722 About The Study: The results of this systematic review…
Visual Abstract: Effect of Community Health Worker Intervention on Acute Care Use in Advanced Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1997?guestAccessKey=4689aac9-0b9e-49bc-ba6e-af3010634318&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 Visual Abstract…
Visual Abstract: Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2253?guestAccessKey=d809d096-4cd9-4e27-9c36-c802e22956bd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 Visual Abstract Authors: Ning…
JAMAONCO_OF:06302022
Opioid Management in Individuals With Advanced Cancer-Related Pain, Opioid Misuse or Use Disorder
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2191?guestAccessKey=5a825031-95be-41f4-8be4-9f3be6dd5772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022 About The Study: The findings of this…